What is Zacks Research’s Estimate for STERIS Q1 Earnings?

STERIS plc (NYSE:STE) – Analysts at Zacks Research upped their Q1 2026 earnings per share estimates for STERIS in a report released on Tuesday, February 25th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will post earnings of $2.31 per share for the quarter, up from their prior estimate of $2.27. The consensus estimate for STERIS’s current full-year earnings is $9.08 per share. Zacks Research also issued estimates for STERIS’s Q2 2026 earnings at $2.36 EPS, Q1 2027 earnings at $2.62 EPS, Q2 2027 earnings at $2.69 EPS, Q3 2027 earnings at $2.81 EPS and FY2027 earnings at $10.72 EPS.

STE has been the subject of a number of other reports. Stephens reissued an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler increased their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Price Performance

STE stock opened at $222.97 on Thursday. STERIS has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market cap of $21.91 billion, a price-to-earnings ratio of 47.34 and a beta of 0.84. The business has a fifty day moving average of $214.13 and a two-hundred day moving average of $223.13.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of STE. Mackenzie Financial Corp increased its position in STERIS by 12.9% in the 4th quarter. Mackenzie Financial Corp now owns 9,399 shares of the medical equipment provider’s stock valued at $1,932,000 after acquiring an additional 1,074 shares during the period. Forum Financial Management LP raised its stake in shares of STERIS by 7.1% during the fourth quarter. Forum Financial Management LP now owns 1,184 shares of the medical equipment provider’s stock worth $243,000 after purchasing an additional 78 shares during the last quarter. GF Fund Management CO. LTD. acquired a new stake in shares of STERIS during the fourth quarter worth $509,000. Public Employees Retirement System of Ohio grew its position in STERIS by 5.2% in the 4th quarter. Public Employees Retirement System of Ohio now owns 46,200 shares of the medical equipment provider’s stock valued at $9,497,000 after buying an additional 2,272 shares during the last quarter. Finally, Fourth Dimension Wealth LLC acquired a new stake in shares of STERIS in the 4th quarter worth $76,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.02%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.